Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor

Epidermal growth factor receptor (EGFR) inhibitors are widely used in the treatment of cancer. EGFR-targeted treatment is known to be associated with a high incidence of dermatological adverse reactions, including papulopustular rash, which can be dose-limiting and may affect compliance to treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Bangsgaard, Nannie, Houtkamp, Mischa, Schuurhuis, Danita H., Parren, Paul W. H. I., Baadsgaard, Ole, Niessen, Hans W. M., Skov, Lone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382563/
https://www.ncbi.nlm.nih.gov/pubmed/22761877
http://dx.doi.org/10.1371/journal.pone.0039706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382563/
https://www.ncbi.nlm.nih.gov/pubmed/22761877
http://dx.doi.org/10.1371/journal.pone.0039706

Ejemplares similares